SURGALIGN HOLDINGS, INC. Quarterly Nonoperating Income (Expense) in USD from Q1 2016 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Surgalign Holdings, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2016 to Q1 2023.
  • Surgalign Holdings, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2023 was $5.42M, a 40.5% decline year-over-year.
  • Surgalign Holdings, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2023 was $19.1M, a 17.4% decline year-over-year.
  • Surgalign Holdings, Inc. annual Nonoperating Income (Expense) for 2022 was $22.8M, a 69.1% increase from 2021.
  • Surgalign Holdings, Inc. annual Nonoperating Income (Expense) for 2021 was $13.5M, a 3868% increase from 2020.
  • Surgalign Holdings, Inc. annual Nonoperating Income (Expense) for 2020 was $340K, a 772% increase from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $19.1M $5.42M -$3.69M -40.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $22.8M $7.71M +$3.78M +96.3% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 $19M -$1.8M -$9.19M -124% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $28.2M $7.79M +$5.08M +187% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $23.1M $9.11M +$9.65M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $13.5M $3.93M +$3.65M +1323% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $9.84M $7.39M +$7.34M +17483% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $2.5M $2.72M +$2.5M +1159% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$7K -$541K -$347K -179% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $340K $276K -$4.94M -94.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $5.28M $42K +$89K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $5.19M $216K +$3.84M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $1.35M -$194K +$1.31M +87.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $39K $5.22M +$2.69M +106% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-15
Q3 2019 -$2.65M -$47K +$551K +92.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$3.2M -$3.63M -$2.48M -215% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$723K -$1.5M -$729K -94.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-30
Q4 2018 $6K $2.53M +$14K +0.56% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-16
Q3 2018 -$8K -$598K +$83K +12.2% Jul 1, 2018 Sep 30, 2018 10-K/A 2020-06-08
Q2 2018 -$91K -$1.15M -$161K -16.3% Apr 1, 2018 Jun 30, 2018 10-K/A 2020-06-08
Q1 2018 $70K -$775K +$24K +3% Jan 1, 2018 Mar 31, 2018 10-K/A 2020-06-08
Q4 2017 $46K $2.52M +$3.18M Oct 1, 2017 Dec 31, 2017 8-K 2020-12-30
Q3 2017 -$3.13M -$681K -$307K -82.1% Jul 1, 2017 Sep 30, 2017 10-K/A 2020-06-08
Q2 2017 -$2.83M -$990K -$566K -133% Apr 1, 2017 Jun 30, 2017 10-K/A 2020-06-08
Q1 2017 -$2.26M -$799K -$485K -154% Jan 1, 2017 Mar 31, 2017 10-K/A 2020-06-08
Q4 2016 -$1.78M -$664K Oct 1, 2016 Dec 31, 2016 10-K/A 2020-06-08
Q3 2016 -$374K Jul 1, 2016 Sep 30, 2016 10-K/A 2020-06-08
Q2 2016 -$424K Apr 1, 2016 Jun 30, 2016 10-K/A 2020-06-08
Q1 2016 -$314K Jan 2, 2016 Mar 31, 2016 10-K/A 2020-06-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.